Home Health Care & Hospital

Health Care & Hospital

    BioVaxys Provides Viral Vaccine Platform Program Update

    0
    Titer Analysis Confirms 100% Efficacy at All Higher Dose Levels in Murine Mouse Study; Preclinical Data Supports Expansion of Vaccine Platform Across Range of Viral DiseasesVancouver, British...

    Relay Medical: Glow LifeTech Receives Conditional Approval to List on the Canadian Securities Exchange

    0
    Toronto, Ontario--(Newsfile Corp. - November 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is...

    NervGen Pharma Reports Third Quarter 2020 Results and Provides Operational Update

    0
    Vancouver, British Columbia--(Newsfile Corp. - November 19, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative...

    Novo Integrated Sciences, Inc. Engages Investor Acquisition Advisors

    0
    Bellevue, Washington--(Newsfile Corp. - November 18, 2020) -  Novo Integrated Sciences, Inc. (OTCQB: NVOS), a provider of multi-dimensional primary healthcare services and products in Canada and the...

    Nass Valley Gateway LTD Announces Its Full Line of Products are Now Available on...

    0
    Vancouver, British Columbia--(Newsfile Corp. - November 16, 2020) - Nass Valley Gateway LTD., (CSE: NVG); (OTC Pink: NSVGF) (FSE: 3NVN) a distributor of top quality non-GMO health...

    NeuPath Health Inc. Announces Closing of Previously Announced $12 Million Bought Deal Financing

    0
    Toronto, Ontario--(Newsfile Corp. - November 13, 2020) - NeuPath Health Inc. (TSXV: NPTH) ("NeuPath" or the "Company"), Canada's largest provider of chronic pain management services, is...

    BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine...

    0
    Vancouver, British Columbia--(Newsfile Corp. - November 11, 2020) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) ("BioVaxys") is pleased to announce that results from its preclinical...

    NervGen Pharma Retains Dr. George Perry to Advise on Alzheimer’s Disease Program and Renews...

    0
    Vancouver, British Columbia--(Newsfile Corp. - November 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating...

    Encode Ideas, L.P. Announces the Initiation of Research Coverage on Ocuphire Pharma Inc.

    0
    Dover, Delaware--(Newsfile Corp. - November 9, 2020) - Encode Ideas, L.P. Initiates Research on Ocuphire Pharma Inc. (NASDAQ: OCUP). The full research publication is available here...

    BioVaxys Engages Advisor for Strategic Business Development

    0
    Vancouver, British Columbia--(Newsfile Corp. - November 9, 2020) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it...
    14,782FansLike
    796FollowersFollow

    Recent Posts

    Please turn AdBlock off